Insulin Potentiation Therapy (IPT), also known as low dose chemotherapy, is an intravenous alternative cancer treatment.The specialized therapy is a non-diabetic use of the hormone insulin to dramatically improve effectiveness and delivery of standard medications and lower doses of chemotherapy to treat cancer.In Insulin Potentiation Therapy, insulin administration does cause the blood glucose to go down. This is called hypoglycemia. This hypoglycemia is an anticipated side-effect of the insulin, one rapidly and effectively controllable with intravenous glucose infusions at an appropriate time, according to the IPT protocol.As part of the approach to integrative cancer support and treatment, we may offer, where appropriate, targeted low dose chemotherapy with biological modulators, also known as TLD/IPT, Target Low dose insulin potentiation therapy, which is a type of fractionated chemotherapy. With the patient’s involvement in weighing the risks and benefits.Effective drug therapy ranks. one must provide insulin at optimal levels for a specified time period–a challenging task. Lastly, targeted drug delivery to the tumor–and not to normal tissue–is a.


This video, https://www.youtube.com/watch?v=3kaAGdxo88Q, can also be seen at https://www.youtube.com/playlist?list=PLKTjY73tu_19v68gYm8XbG69KiZgXdiX4.Usage of low doses chemotherapeutics with increased frequency suggests another method called insulin-potentiated therapy (IPT) or now called insulin-potentiated targeted low-dose therapy (IPTLD), where standard schemes of chemotherapy are used in combination with intravenous insulin, 10 times lower doses of chemotherapeutics, and short.Also known as IPTLD or Insssulin Potentiation Low Dose Therapy is a metabolic supported chemotherapy that includes: fasting, IPT and traditional chemotherapy. ipt is one of our key therapies in the Functional Oncology Clinic and we are proud to say that Dr. Donato Perez, one of our specialists is the grandson of the IPT creator and the rightful owner of IPTLD therapy.In the coming years, if IPT gets the scientific substantiation to prove its theory, then it probably will become part of the authorized cancer treatments. However, right now it has inadequate scientific evidence and research in its support, and therefore professional oncologists don’t recommend insulin potentiation therapy.Why You Should Stay Away from Insulin potentiation therapy robert baratz, M.D., D.D.S., Ph.D. Insulin potentiation therapy (IPT) is one of several unproven, dangerous treatments that is promoted by a small group of practitioners without trustworthy evidence that it works.